India Revokes Patent on Merck & Co Asthma Drug

Published December 11, 2012

India revokes patent on Merck & Co asthma drug

Filed under: drug treatment news 2012

MUMBAI | Tue Dec 11, 2012 7:24pm IST. MUMBAI (Reuters) – India has revoked a patent granted … The move is the latest in a series of patent cancellations by India, where generic medicines account for more than 90 percent of drug sales by value and …
Read more on Reuters India

Investigation Shows Advair Inappropriately Used for Mild Asthma

Filed under: drug treatment news 2012

A news investigation has found that growth of a blockbuster asthma drug linked to serious risks came after doctors who received money from the manufacturer issued new treatment recommendations. GlaxoSmithKline's Advair has been prescribed for millions …
Read more on DrugWatch.com

Seattle Genetics Readies Phase III Trial for Adcetris

Filed under: drug treatment news 2012

… released mixed data regarding Adcetris' use in clinical trials for non-Hodgkin's lymphoma in a separate release. The company picked up orphan-drug status from the FDA in November for Adcetris' treatment of a certain type of Non-Hodgkin's lymphoma …
Read more on DailyFinance